Professional Documents
Culture Documents
Wa0000
Wa0000
biological studies
Siddram Nadigar M.S.a, Dileep D.N.a, Rekha N.D.b, Rohith Ga, Suhas Ra*
aPostgraduate Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru-25
bPostgraduate Department of Biotechnology, JSS College of Arts, Commerce and Science, Ooty Road, Mysuru-25
Presentation by
SIDDARAM NADIGAR M.S.
Research Scholar
J.S.S. College, Ooty Road, Mysuru-25
1
Biological applications Other applications
Anticancer Antimicrobial
Anti-
Antioxidant inflammatory
2
Drugs containing pyrazolines
Sl. No. DRUG STRUCTURE APPLICATIONS
NAME
1 Ibipinabant Selective cannabinoid
CB1 receptor inverse
agonist
2 YC-1 Anticancer
3
Problems associated with the existing synthetic protocols
➢ Flammable solvents
➢ More reaction time
➢ Non-ecofriendly
➢ Harsh bases
4
BASES REMARKS SOLVENTS REMARKS TIME REMARKS
NaOH 1h incomplete, 2h Ethanol Impurity
30 min Partial reaction
good reaction; DCM Impurity
Emulsion during 1h Complete & clear
workup H2O No reaction
reaction
Na2CO3 Incomplete reaction THF Impurity
2h Complete reaction
ACN Very good reaction,
KOH Impurity, Incomplete
Impurity 4h Complete reaction
rection
Toluene Impurity (impurity)
Pyridine 1h, good reaction
DMSO Very good product (1h) 8h Impurity formation
TEA 3h, good reaction
Triethanol Incomplete reaction TEMPERATURE REMARKS
12h Impurity formation
amine 0 0C No reaction
24h More impurities
K2CO3 Very good reaction Rt No reaction
(1h) 5
Reflux 1h
Synthetic Scheme
6
Interactions and docking score
Entry R R1 R2 Score H-bonding van der Waals Pi- Pi-sigma Pi-alkyl
Kcal/mol anion
2a H Ph CH3 -5.8 Arg-A:452 Trp-A:576, Pro-A:575, Gly- Asp- Ala-A;455 Ala-A;572
A:451, Gly-A:573, Ile-A:425, A:568
Ala-A:573, Phe-A:449,Thr-
A:566,Thr-A:450
2b 2-OH, Ph CH3 -6.0 Gly-A:451, Trp- Gly-A:426, Arg-A:452, Ala- Asp- _ Ala-A:572
A:576, Lys-A:435 A:572,A:573, Thr-A:450, Ile- A:568
5-NO2 A:592
2c 4-OH CH3 CH3 -5.1 Trp-A:576 Thr-450, Asp-568, Gly- _ _ Ala-455,572, Pro-575, Arg-
574,451,576, Ile-425 452
2d 4-Cl C6H10 C6H10 -4.9 Ile-A:425 Gly-A:426,A:451, Ala-A:572,573, Asp- His-A:569 Ala-A:455,A:572, Pro-A:575
Thr-A:450, Trp-A:576, Ile-592 A:568
2e 2,3- C6H10 C6H10 -6.3 Thr-A:450 Gly-A:593, Thr-A:450, Lys- _ _ Ala-A:455, Phe-A:449, Arg-
A:564, Ala-A:573,A:455, Pro- A:452
OMe A:575, Ile-A:425
2f 3,4- COCH3 CH3 -5.4 Ile-A:425 Gly-A:451, Ala-A:573, Thr- _ _ Ala-A;572, His-A:569, Pro-
A:450, Arg-A:447 A:575, Phe-A:449, Trp-
OMe A:576
2i 3,4- C6H10 C6H10 -5.6 Arg-A:452 Ala-A:572, Gly-A:451,574,426, _ _ Arg-A:452, Phe-A:449, Ala-
Pro-A:572575, Asp-A:568, Arg- A:455
OMe A:447, Thr-A:566, Lys-A:564,
7
Ile-A:425
PROTEIN : ACONITASE
Molecular docking studies
PROTEIN ID : 1AMJ
8
Inhibition studies of the aconitase enzyme
9
Entry % of
inhibition
2a 85.45
2b 93
2c 71.46
2d 75.61
2e 93.71
2f 85.71
2g 57.2
2h 51.14
2i 64.56
1.3
1.2 2d
1.1 2e
2f
1
2g
0.9
2h
0.8
1 2 3 4 5 2i
Concentration in µg
12